Placebo (for 40 μg/kg Group)

DRUG2 trials

Sponsors

Jecho Biopharmaceuticals Co., Ltd.

Conditions

HIV Infections

Phase 1

A Study to Evaluate JL18008 in Subject With HIV Immunological Non-Responders

RecruitingNCT07579741

Jecho Biopharmaceuticals Co., Ltd.HIV Infections

Start: 2026-05-26End: 2027-09-28Target: 30Updated: 2026-08-06

To Evaluate the Safety of JL18008

CompletedNCT07629310

Jecho Biopharmaceuticals Co., Ltd.HIV Infections

Start: 2024-06-13End: 2025-08-05Updated: 2026-06-11